激光显微切割与质谱法表征IgA肾病中IgA、IgA免疫复合物及补体沉积
该研究对22例IgA肾病肾组织采用激光显微切割与质谱法(LMD/MS)表征IgA和补体沉积,发现IgA1、IgA2、J链和IgG1普遍沉积,补体以旁路途径和终末途径激活为主,并检出多种补体调节蛋白。
要点
- IgA肾病沉积物含黏膜来源的二聚体IgA1/IgA2及IgG1。
- 补体激活以旁路途径和终末途径为主,C4沉积较少。
- 病灶中检出CFH、CFHR1、CFHR2、CFHR5、CD59等补体调节蛋白。
核心结论
- IgA免疫复合物由黏膜来源的二聚体IgA1/IgA2和IgG1组成。
- 检出的补体蛋白多数属于旁路途径和终末途径组分。
研究设计与样本
- 研究纳入22例IgA肾病病例,采用激光显微切割与质谱法(LMD/MS)表征肾小球IgA和补体沉积。
- 辅以IgG亚类染色和共聚焦免疫荧光显微镜验证。
主要发现
- LMD/MS检测到IgA1和IgA2分别见于100%和82%的病例。
- J链见于91%的病例,聚合Ig受体仅见于9%的病例。
- IgG1为优势IgG亚类,见于100%的病例,并与IgA1和IgA2共定位。
- 补体检测显示C3、C9、C5、C6、C7、C8丰富,C4较少。
- 检出CFH、CFHR1、CFHR2、CFHR5、CD59及少量CFB;C3序列覆盖显示多数氨基酸属于C3dg,少量属于C3c。
临床怎么用
- 提示IgA肾病补体激活以旁路和终末途径为主,支持相关通路作为潜在治疗靶点。
- IgG1共沉积及补体调节蛋白高表达可能与活动性病变相关,需进一步验证。
局限性
- 样本量仅22例,部分发现(如C3、C5、C9与病变关联)未达统计学显著性。
- 原文未报告统计检验的具体P值或置信区间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: IgA nephropathy is characterized by accumulation of mesangial IgA immune complexes. These IgA immune complexes result in glomerular inflammation and subsequent sclerosis. Glomerular inflammation is mediated in part by activation of the complement pathway by these immune complexes. METHODS: In this study of 22 cases of IgA nephropathy, using laser microdissection and mass spectrometry (LMD/MS), we characterized both IgA and complement deposits. RESULTS: LMD/MS detected abundant IgA1 but also IgA2; detected in 100% and 82% of cases, respectively. Furthermore, J chains, that link IgA monomers to form dimeric IgA on mucosal surfaces, was detected in 91% of cases, while the polymeric Ig receptor found in secretory IgA was found in only 9% of the cases. IgG1 was the dominant IgG subclass and was detected in 100% of cases. IgG subclass staining and confocal immunofluorescence microscopy confirmed the IgG1 subclass and colocalization of IgG1 with IgA1 and IgA2.Evaluation of the complement pathways revealed abundant C3, C9, C5, C6, C7 and C8 with lesser amounts of C4 indicating activation of predominantly the alternative and terminal pathways of complement. LMD/MS also detected abundant complement regulating proteins including CFH, CFHR1, CFHR2 and CFHR5, CD59, and smaller amounts of CFB, indicating active regulation of the complement pathways. Although it did not reach statistical significance, high counts of C3, C5 and C9 were present in lesions with endocapillary hypercellularity/crescentic lesions. High counts of complement regulating proteins, particularly CFHR5, were also present in active lesions. C3 sequence coverage data showed the majority of amino acids detected belong to C3dg along with smaller amounts of C3c. CONCLUSION: Our data shows that the IgA immune complexes are composed of mucosal-derived dimeric IgA1/IgA2 and IgG1. The majority of complement proteins detected are components of the alternative and terminal complement pathway.
引用
- Cara A, Singh RD, Berti GM, et al. Characterization of IgA, IgA immune complexes and complement depositions in IgA nephropathy using laser microdissection and mass spectrometry. Kidney Int. 2026. PMID: 42918416. doi:10.1016/j.kint.2026.09.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。